Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 5 search results for "Mylotarg" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Acute Myeloid Leukemia Treatment Options
... Sometimes, targeted therapies such as those listed below, are used in combination with low-intensity chemotherapy to treat AML: Rydapt (Midostaurin) for AML cells with an FLT3 gene mutation Xospata (Gilteritinib) Venclexta (Venetoclax) Daurismo (Glasdegib) Other agents have recently been approved for specific AML cases: Mylotarg (Gemtuzumab ozogamicin ...
Acute Myeloid Leukemia Treatment Options
... Sometimes, targeted therapies such as those listed below, are used in combination with low-intensity chemotherapy to treat AML: Rydapt (Midostaurin) for AML cells with an FLT3 gene mutation Xospata (Gilteritinib) Venclexta (Venetoclax) Daurismo (Glasdegib) Other agents have recently been approved for specific AML cases: Mylotarg (Gemtuzumab ozogamicin ...
The Benefits of Targeted Therapy for Leukemia
... Gemtuzumab ozogamicin (Mylotarg) is an antibody combined with a chemotherapy drug. This targeted therapy works by attaching to AML cells, forcing them to come into contact with the chemotherapy. This helps kill the cells.Two drugs in this category are approved to treat ALL. ...
The Benefits of Targeted Therapy for Leukemia
... Gemtuzumab ozogamicin (Mylotarg) is an antibody combined with a chemotherapy drug. This targeted therapy works by attaching to AML cells, forcing them to come into contact with the chemotherapy. This helps kill the cells.Two drugs in this category are approved to treat ALL. ...
Acute Myelomonocytic Leukemia (AMML): An Overview
... One common targeted therapy used for AMML is Mylotarg (Gemtuzumab ozogamicin). This drug has been approved by the U.S. Food and Drug Administration (FDA) to treat AML cells that contain a protein called CD33. Immature AMML cells often contain this protein. Gemtuzumab ozogamicin has two parts. One part is an antibody that attaches to CD33. ...
Acute Myelomonocytic Leukemia (AMML): An Overview
... One common targeted therapy used for AMML is Mylotarg (Gemtuzumab ozogamicin). This drug has been approved by the U.S. Food and Drug Administration (FDA) to treat AML cells that contain a protein called CD33. Immature AMML cells often contain this protein. Gemtuzumab ozogamicin has two parts. One part is an antibody that attaches to CD33. ...
Mast Cell Leukemia: An Overview
... Mylotarg (gemtuzumab ozogamicin) may also help kill MCL cells that have certain gene and protein changes.ChemotherapyChemotherapy may include the medications Intron A (interferon-alpha) or Mavenclad (cladribine). ...
Mast Cell Leukemia: An Overview
... Mylotarg (gemtuzumab ozogamicin) may also help kill MCL cells that have certain gene and protein changes.ChemotherapyChemotherapy may include the medications Intron A (interferon-alpha) or Mavenclad (cladribine). ...
8 Leukemia Treatment Options You Should Know
... Antibody-drug conjugates used in leukemia include: Gemtuzumab ozogamicin (Mylotarg), used to treat AML Inotuzumab ozogamicin (Besponsa), used to treat ALL Bispecific T-Cell EngagersBispecific T-cell engagers, or BiTEs, have two parts. One part binds to a cancer cell, and the other binds to a T cell. ...
8 Leukemia Treatment Options You Should Know
... Antibody-drug conjugates used in leukemia include: Gemtuzumab ozogamicin (Mylotarg), used to treat AML Inotuzumab ozogamicin (Besponsa), used to treat ALL Bispecific T-Cell EngagersBispecific T-cell engagers, or BiTEs, have two parts. One part binds to a cancer cell, and the other binds to a T cell. ...